pcDNA3.1 SARS-CoV-2 M Citations (3)

Originally described in: Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.
Yurkovetskiy L, Wang X, Pascal KE, Tomkins-Tinch C, Nyalile TP, Wang Y, Baum A, Diehl WE, Dauphin A, Carbone C, Veinotte K, Egri SB, Schaffner SF, Lemieux JE, Munro JB, Rafique A, Barve A, Sabeti PC, Kyratsous CA, Dudkina NV, Shen K, Luban J Cell. 2020 Sep 15. pii: S0092-8674(20)31229-0. doi: 10.1016/j.cell.2020.09.032. PubMed Journal

---

Articles Citing pcDNA3.1 SARS-CoV-2 M

Articles
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilities. Kruse T, Benz C, Garvanska DH, Lindqvist R, Mihalic F, Coscia F, Inturi R, Sayadi A, Simonetti L, Nilsson E, Ali M, Kliche J, Moliner Morro A, Mund A, Andersson E, McInerney G, Mann M, Jemth P, Davey NE, Overby AK, Nilsson J, Ivarsson Y. Nat Commun. 2021 Nov 19;12(1):6761. doi: 10.1038/s41467-021-26498-z. PubMed
The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins. Bains A, Fischer K, Guan W, LiWang PJ. Viruses. 2023 Dec 18;15(12):2452. doi: 10.3390/v15122452. PubMed
A viral assembly inhibitor blocks SARS-CoV-2 replication in airway epithelial cells. Du L, Deiter F, Bouzidi MS, Billaud JN, Simmons G, Dabral P, Selvarajah S, Lingappa AF, Michon M, Yu SF, Paulvannan K, Manicassamy B, Lingappa VR, Boushey H, Greenland JR, Pillai SK. Commun Biol. 2024 Apr 22;7(1):486. doi: 10.1038/s42003-024-06130-8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.